Gencebok is a stimulant medicine used for treating apnoea of prematurity, a condition in which babies born prematurely stop breathing for longer than 20 seconds. Gencebok contains the active substance caffeine citrate. Gencebok is a ‘hybrid’ medicine. This means that it is similar to a ‘reference medicine’ containing the same active substance, but at a different strength. The reference medicine for Gencebok is Peyona.
Therapeutic Indication
### Therapeutic indication Treatment of primary apnoea of premature newborns.
Therapeutic Area (MeSH)
ATC Code
N06BC01
ATC Item
caffeine
Pharmacotherapeutic Group
Psychoanaleptics
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Caffeine citrate | N/A | 咖啡因 |
EMA Name
Gencebok
Medicine Name
Gencebok
Aliases
N/ANo risk management plan link.
